Abacavir
Abacavir, lamivudine, and zidovudine-Trizivir
U.S. BRAND NAMES — Trizivir®PHARMACOLOGIC CATEGORY Antiretroviral Agent, Reverse Transcriptase Inhibitor (Nucleoside)DOSING: ADULTS — HIV treatment: Oral: 1 tablet twice daily. Note: Not recommended for patients <40 kg.DOSING: PEDIATRIC — HIV treatment: Adolescents: Refer to adult dosing (not recommended for patients <40 kg).(For additional information see “Abacavir, lamivudine, and zidovudine: Pediatric drug information”)DOSING: ELDERLY — [...]
Read Full Post | Make a Comment ( None so far )Abacavir and lamivudine-Epzicom
U.S. BRAND NAMES — Epzicom™PHARMACOLOGIC CATEGORY Antiretroviral Agent, Reverse Transcriptase Inhibitor (Nucleoside)DOSING: ADULTS — HIV: Oral: One tablet (abacavir 600 mg and lamivudine 300 mg) once dailyDOSING: RENAL IMPAIRMENT — Clcr <50 mL/minute: Use not recommendedDOSING: HEPATIC IMPAIRMENT — Use contraindicated.DOSAGE FORMS — Excipient information presented when available (limited, particularly for generics); consult specific product [...]
Read Full Post | Make a Comment ( None so far )Abacavir-Ziagen
U.S. BRAND NAMES — Ziagen®PHARMACOLOGIC CATEGORY Antiretroviral Agent, Reverse Transcriptase Inhibitor (Nucleoside)DOSING: ADULTS — HIV treatment: Oral: 300 mg twice daily or 600 mg once daily in combination with other antiretroviral agentsDOSING: PEDIATRIC — HIV treatment: Oral: 3 months to 16 years: 8 mg/kg body weight twice daily (maximum: 300 mg twice daily) in combination [...]
Read Full Post | Make a Comment ( None so far )
